Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream.
Pharmaceutics. 2021 Jul 8;13(7):1044. doi: 10.3390/pharmaceutics13071044.
Pharmaceutics. 2021.
PMID: 34371735
Free PMC article.
Review.